Expanding TAVI to Low and Intermediate Risk Patients
Standard
Expanding TAVI to Low and Intermediate Risk Patients. / Voigtländer, Lisa; Seiffert, Moritz.
In: FRONT CARDIOVASC MED, Vol. 5, 2018, p. 92.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Expanding TAVI to Low and Intermediate Risk Patients
AU - Voigtländer, Lisa
AU - Seiffert, Moritz
PY - 2018
Y1 - 2018
N2 - TAVI has become the standard treatment in patients at increased surgical risk and is increasingly being performed in patients at intermediate to low surgical risk. While non-inferiority has been demonstrated in intermediate risk patients, several challenges-particularly with regard to valve durability-need to be addressed before expansion to lower risk and younger patients can be recommended on a broad basis. Current trends, trials results, and remaining challenges are summarized and discussed in the light of updated treatment guidelines.
AB - TAVI has become the standard treatment in patients at increased surgical risk and is increasingly being performed in patients at intermediate to low surgical risk. While non-inferiority has been demonstrated in intermediate risk patients, several challenges-particularly with regard to valve durability-need to be addressed before expansion to lower risk and younger patients can be recommended on a broad basis. Current trends, trials results, and remaining challenges are summarized and discussed in the light of updated treatment guidelines.
U2 - 10.3389/fcvm.2018.00092
DO - 10.3389/fcvm.2018.00092
M3 - SCORING: Review article
C2 - 30050909
VL - 5
SP - 92
JO - FRONT CARDIOVASC MED
JF - FRONT CARDIOVASC MED
SN - 2297-055X
ER -